Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The human phospholamban gene: structure and expression.

C F McTiernan1, C S Frye, B H Lemster

  • 1Cardiovascular Institute, University of Pittsburgh Medical Center, PA 15213, USA. mctiernanc@msx.upmc.edu

Journal of Molecular and Cellular Cardiology
|April 13, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to "clarification of enrolled subjects in tolvaptan HF trials".

Clinical pharmacology and therapeutics·2014
Same author

Vasopressin antagonists for patients with acute heart failure: interpreting new clinical and translational data.

Clinical pharmacology and therapeutics·2013
Same author

Co-expression of skeletal and cardiac troponin T decreases mouse cardiac function.

American journal of physiology. Cell physiology·2007
Same author

Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts.

Gene therapy·2007
Same author

Polymorphisms in adenosine receptor genes are associated with infarct size in patients with ischemic cardiomyopathy.

Clinical pharmacology and therapeutics·2007
Same author

Developing strategies to link basic cardiovascular sciences with clinical drug development: another opportunity for translational sciences.

Clinical pharmacology and therapeutics·2007
Same journal

Sex- and stressor-dependent effects of metformin on cardiac fibrosis in plasminogen activator inhibitor-1 deficiency.

Journal of molecular and cellular cardiology·2026
Same journal

Large extracellular vesicles derived from red blood cells in coronary artery disease patients with anemia promote endothelial dysfunction.

Journal of molecular and cellular cardiology·2026
Same journal

SnRNA-seq identifies FN1-SDC4 axis triggering epicardial activation in right ventricular remodeling in pulmonary hypertension.

Journal of molecular and cellular cardiology·2026
Same journal

Therapeutic impact of normal dietary patterns on diabetic cardiomyopathy: Transcriptomic and proteomic insights.

Journal of molecular and cellular cardiology·2026
Same journal

Structural, biophysical and cellular assessment of filamin C M82K: A test case for VUS interpretation in cardiomyopathy.

Journal of molecular and cellular cardiology·2026
Same journal

Precision modification of heart failure signaling by CRISPR-Cas9 base editing.

Journal of molecular and cellular cardiology·2026
See all related articles

Human phospholamban (PLB) is crucial for heart function. This study characterized PLB expression in human organs and identified key regulatory elements in its gene promoter, revealing tissue-specific activity essential for cardiac muscle relaxation.

Area of Science:

  • Molecular Biology
  • Cardiovascular Physiology
  • Gene Regulation

Background:

  • Phospholamban (PLB) regulates cardiac sarcoplasmic reticulum calcium-ATPase (SERCA) activity, impacting diastolic function and muscle relaxation.
  • Altered PLB expression is observed in heart failure, but human gene regulation remains poorly understood.

Purpose of the Study:

  • To characterize human phospholamban expression across various organs.
  • To isolate the human phospholamban gene and identify its regulatory elements.
  • To investigate the tissue-specific promoter activity of the human phospholamban gene.

Main Methods:

  • Human organ phospholamban transcript and protein levels were analyzed.
  • Genomic clones of the human phospholamban gene were isolated.

Related Experiment Videos

  • Promoter-luciferase reporter constructs were used in transient transfection assays in cardiomyocytes and HeLa cells.

    • Main Results:

    • High phospholamban expression was found in human ventricle and quadriceps, with lower levels in smooth muscle and right atria.
    • The human phospholamban gene shows conserved upstream sequences with potential regulatory motifs (GATA, CP1/NFY, M-CAT, E-box).
    • A region between -169 and -93 (containing the CP1-box) was critical for maximal promoter activity in cardiomyocytes, indicating tissue selectivity.

    Conclusions:

    • Human phospholamban exhibits differential expression across tissues, notably high in cardiac ventricles and skeletal muscle.
    • Conserved regulatory elements in the human phospholamban gene promoter suggest important functional roles.
    • The identified promoter region is essential for maximal activity in cardiomyocytes, highlighting tissue-specific gene regulation for cardiac function.